Skorpios Trust
SEC CIK 1869333 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| STOK | Stoke Therapeutics, Inc. | 10% | 3.91M | — | $30.60M | 1 | 2025-06-04 | 2025-06-04 |
Most active insiders at STOK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Krainer Adrian R. | Dir | — | $3.90M |
| 2 | Kaye Edward M. MD | Dir | — | $3.18M |
| 3 | Ticho Barry | Chief MEDICAL Off | — | $1.98M |
| 4 | Allan Jonathan | GC, CORP SEC | — | $1.56M |
| 5 | TZIANABOS ARTHUR | Interim Executive COB, Dir | — | $174.2K |
| 6 | Leggett Thomas | CFO | — | $147.1K |
| 7 | Hoitt Jason | Chief Patient Off | — | $119.3K |
| 8 | LEVIN ARTHUR A | Dir | — | $22.3K |
Skorpios Trust made no open-market trades at STOK in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-06-06 | 2025-06-04 | STOK | Stoke Therapeutics, Inc. | Skorpios Trust | 10% | S - Sale | $10.20 | -3.00M | 3.91M | -43% | -$30.60M |
Purchase Sale Sale after option exercise All abbreviations